^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BYON4228

    i
    Other names: BYON4228, CD47-SIRPα mAb, CD47/SIRPalpha pathway modulator, CD47/SIRPα mAb, CD47-SIRP alpha mAb
    Associations
    News
    Trials
    Company:
    Byondis
    Drug class:
    SIRPA inhibitor
    Related drugs:
    Associations
    News
    Trials